All-oral therapy with nucleotide inhibitors sofosbuvir and GS-0938 for 14 days in treatment-naive genotype 1 hepatitis C (NUCLEAR)
Article first published online: 31 MAR 2013
© 2013 Blackwell Publishing Ltd
Journal of Viral Hepatitis
Volume 20, Issue 10, pages 699–707, October 2013
How to Cite
Lawitz, E. J., Rodriguez-Torres, M., Denning, J., Mathias, A., Mo, H., Gao, B., Cornpropst, M. T., Berrey, M. M. and Symonds, W. T. (2013), All-oral therapy with nucleotide inhibitors sofosbuvir and GS-0938 for 14 days in treatment-naive genotype 1 hepatitis C (NUCLEAR). Journal of Viral Hepatitis, 20: 699–707. doi: 10.1111/jvh.12091
- Issue published online: 8 SEP 2013
- Article first published online: 31 MAR 2013
- Manuscript Accepted: 1 FEB 2013
- Manuscript Received: 1 JAN 2013
- Gilead Sciences
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.